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Abstract 
Background: Asymptomatic bacteriuria (ASB) is common among women with diabetes. The aim of 
this study was determine the prevalence of and risk factors for ASB in women with diabetes type 2 in 
Shahre-kord city of Iran. 
Methods: In a six months period (April- September 2005), a total of 100 women with diabetes (type 
2) and 100 healthy women without diabetes as control group were investigated for the presence of 
ASB. After a follow-up of six months, the rate of developing of ASB to symptomatic urinary tract in-
fection (UTI) in patients was evaluated. 
Results: The prevalence of ASB was 20% in the diabetic patients and 4% in control group (P< 0.05). 
Escherichia coli, Coagulase negative staphylococci, Enterococcus spp. and Klebsiella pneumoniae 
were the most prevalent isolates respectively. Pyuria was present in 80% of patients with ASB and in 
17.5% of those without ASB. Symptomatic UTI in previous year was the only risk factor for ASB in 
the patients (P< 0.05). During a follow-up of six months, 40% of diabetic patients with ASB devel-
oped to symptomatic UTI. 
Conclusions: The prevalence of ASB is increased in women with diabetes and we recommend 
screening for detection and treatment of ASB in diabetic patients. 
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Introduction 
Diabetes type 2, also known as non insulin-
dependent diabetes (NIDDM), is One of the 
two major types of diabetes in which the 
beta cells of the pancreas produce insulin but 
the body is unable to use it effectively be-
cause the cells of the body are resistant to 
the action of insulin (1, 2). Patients with dia-
betes have an increased risk of infections, 
with the urinary tract being the most preva-
lent infection site (2, 3). Besides, the rates of 
complications of urinary tract infection (UTI) 
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and upper tract involvement are much higher 
than in the general population.  
Asymptomatic bacteriuria (ASB) in diabetic 
patients is contributed with increased risk of 
symptomatic UTI (4, 5). ASB is defined as 
the presence of at least 105 colony-forming 
units (CFU)/ ml of 1 or 2 bacterial species in 
clean-voided midstream urine sample from 
an individual without symptoms of a UTI 
(1). The prevalence of asymptomatic bacte-
riuria is about 3 times higher in diabetic 
women (ranging from 15% to 30%) than in 
nondiabetic women (less than 10%) (1, 6-8). 
Local secretion of cytokines and increased 
adherence of uropathogens to uroepithelial 
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cells have been proposed to account for the 
greater prevalence of bacteriuria in diabetic 
persons (6, 9). The prevalence of pyuria in 
young nondiabetic women with ASB is 
about 32%. This rate in diabetic women is 
calculated about 70%-80% (10, 11).   
Various risk factors for ASB in women with 
diabetes have been suggested, including 
sexual intercourse, age, duration, metabolic 
control, and complications of diabetes (4, 8, 
10, 12, 13). Some studies showed that, the 
number of symp-tomatic UTI in the previous 
year increased the risk of developing ASB in 
diabetic women (14). Mendusa and cowork-
ers (7) postulated that there was no associa-
tion between fasting glucose concentration 
and ASB in diabetic women.  
Escherichia coli, in diabetic patients, as in 
others is the most common uropathogen (7, 
10). Other Enterobacteriaceae including Pro-
teus, Klebsiella, Enterobacter and Citrobacter 
spp., Pseu-domonas aeruginosa, Enterococ-
cus spp., Gardnerella vaginalis, Streptococ-
cus and Staphylococcus spp., Candida albi-
cans and other fungi have been reported (7, 
10, 15). The probability of a more severe 
course of the infection and the proportion of 
resistant pathogens is also higher in diabetic 
patients than in nondiabetic patients (4, 6, 16).  
There is a trend in clinical practice to treat 
patients with diabetes who have asympto-
matic bacteriuria (4). Some studies have not 
recommended the antibacterial treatment of 
ASB for prevention of UTI complications in 
diabetic patients (4, 6, 17). In contrast, other 
reports have suggested at least 1 course of 
appropriate antibiotic therapy in an effort to 
eradicate the pathogen or the postulated 
pathogen from the urinary tract (1, 11, 15, 
18); although in some reports, this is based 
solely on empiric evidence (18).  
Some studies (19) have reported that decreas-
ing renal functional tests is a consequence of 
ASB in diabetic patients. Geerlings (20) 
showed that 23% of patients with diabetes 
type 2 and ASB developed to symptomatic 
UTI within 2 mo and postulated that ASB was 
the most important risk factor for developing 
UTI in diabetic women. Regarding to these 
reports and because more UTI complications 
(e.g., bacteremia, renal abscesses, renal pap-
illary necrosis) are seen in patients with dia-
betes versus individuals without diabetes 
(21) and also no published results about ASB 
especially in diabetic patients in Iran were 
available, investigating the association be-
tween ASB and symptomatic UTI in women 
with diabetes and need to initiation of ther-
apy in these patients is important. 
The aim of the present study, therefore, was 
to determine the prevalence of and the risk 
factors for ASB in 100 women with type 2 
diabetes in Shahre-kord city (the center of 
Chahar-mahal Province) of Iran.  
 
Materials and Methods 
In a six months period (April- September 
2005), and in  an analytical cross- sectional 
study, a total of 100 non-pregnant women 
with diabetes (type 2) who were 31-81 yr of 
age and had no abnormalities of the urinary 
tract and 100 healthy women without diabe-
tes (28-74 yr of age) as control group were in-
cluded. The groups were matched together 
demographically. Two groups were investi-
gated for the presence of ASB, which was 
defined as the presence of at least 105 colony 
forming units/ ml of 1 or 2 bacterial species in 
a culture of clean- voided midstream urine 
from an individual without symptoms of 
UTI. Urine samples were kept at 4 ºC up to 2 
h before culture. The urine was plated onto 
5% sheep blood agar (Difco) and MacCon-
key agar (Difco) plates in two separated 
plates. A calibrated loop designed to deliver 
0.01 mil-liliter of urine was used for urine 
inoculation. For this, the plates were 
streaked by touching the loop to the center 
of the plate, from which the inoculum spread 
in a line across the diameter of the plate. 
Then, loop was drawn across the entire plate, 
crossing the first inoculum streak numerous 
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times to produce isolated colonies. Once 
plated, urine cultures were incubated at 35 ºC. 
The results were read after 24 h. Colonies 
were counted on each plate. The number of 
colony forming units (CFUs) was multiplied 
by 100 to determine the number of microor-
ganisms per milliliter in the original speci-
men (22). The presence of WBCs>/= 10/mm3 
of urine was considered as significant pyuria 
(22). Microorganisms were identified accord-
ing to standard bacteriologic procedures (22). 
Exclusion criteria were pregnancy, recent hos-
pitalization or surgery (within the past 4 mo), 
known urinary tract abnormalities or recent 
urinary tract instrumentation, symptoms of a 
UTI (the presence of dysuria, frequency or 
urgency, abdominal discomfort or fever), or 
the use of antimicrobial drugs during the 
previous 14 d. A consent form was filled in 
by the patients in the beginning of the study. 
The patients who developed to symptomatic 
UTI were referred to urologist for further 
evaluation and initiation of therapy. All pa-
tients were interviewed during the first visit 
of the study and their medical history was 
obtained using a standardized questionnaire. 
The questionnaire included age, duration of 
diabetes, and urinary tract surgery during the 
previous years and past history of UTIs 
during the past year. Laboratory values con-
taining serum creatinine, pyuria and fasting 
glucose concentration were also obtained. 
During a follow-up of six mo development 
of ASB into symptomatic upper or lower uri-
nary tract infections were determined. Risk 
factors were analyzed according to the dif-
ferences between patients with and those 
without ASB. 
Differences between patients with and with-
out ASB were tested with t test for continu-
ous variables (age and duration of diabetes). 
Chi- square test was used for variables pyu-
ria and number of UTIs during the past year. 
P< 0.05 was considered to be statistically 
significant. SPSS statistical software for win-
dows (version 11) was used. 
Results 
Of the total study group (n= 100) with type 2 
diabetes, 20% had ASB. Only 4% of nondia-
betic patients (control group) had ASB (P< 
0.05). Pyuria was present in 80% 0f diabetic 
and 25% of non-diabetic patients with ASB 
(P< 0.05). Escherichia coli was isolated in 
55% of patients with ASB. Other isolated 
microorganisms included coagulase-negative 
Staphylococcus spp. (20%), Enterococcus spp. 
(15%), and Klebsiella pneumoniae (10%).  
Eighty percent of diabetic women with ASB 
and 17.5% of those without ASB had pyuria 
(P< 0.05). Besides, forty percent of diabetic 
women with ASB had past history of symp-
tomatic UTI in the past year. There was no 
correlation between age, fasting glucose con-
centration, duration of diabetes and the pres-
ence of ASB in diabetic women. In contrast, 
significant association was evident between 
symptomatic UTI during the past year and 
the presence of ASB in patients (P< 0.05) 
(Table 1). Chi- square test showed that no 
association was evident between past history 
of UTI and presence of pyuria. During a 
follow-up of six mo, 40% (eight patients) of 
diabetic women with ASB had at least one 
episode of symptomatic UTI. Five (62.5%) 
diabetic patients with ASB developed to 
symptomatic lower UTI (cystitis) and symp-
tomatic upper UTI (pyelonephritis) was de-
tected in three (37.5%) of them. In diabetic 
patients without ASB, symptomatic lower 
UTI was detected in only five (6.3%) patients 
(P< 0.05). Upper UTI was not found in these 
patients. There was an association between 
age and developing of ASB to symptomatic 
UTI in our patients (P= 0.034). No associa-
tion was found between duration of diabetes, 
fasting glucose concentration and develop-
ing UTI in diabetic patients with ASB (Table 
2). Besides, in our study, no association was 
found between serum creatinine and pres-
ence of ASB in diabetic women. 
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Table 1: Risk factors for women with diabetes type 2 
 
Risk factors ASB+ ASB- OR P 
n (%) 20 (20) 80 (80)   
Age (yr) 60.37+/- 11.8 60.37 +/- 11.8  0.14 
Duration of diabetes (mo)   98.87 +/- 89.34 73.04 +/- 83.29  > 0.05 
History of UTIs during the previous year (%)       40 5  < 0.05 
Fasting glucose concentration (mg/dl)      205.34+/- 92.20 184.6+/- 82.8 0.165  
 
Data are n (%), means +/- SDs, or Odds Ratios, ASB: Asymptomatic bacteriuria, UTI: Urinary tract infection 
 
Table 2: Risk factors contributed with developing to symptomatic urinary tract infection (UTI) in ASB positive 
diabetic women. 
 
Risk factors                                            
 
ASB + patients            
Developed to UTI 
ASB + patients Not 
developed to UTI 
P 
Age (yr)    56.87 +/- 11.49 67.20 +/- 7.36 0.034 
 
Duration of diabetes (mo)                        56.63 +/- 94.09 73.5 +/- 72.64 0.67 
 
Fasting glucose concentration (mg/dl)    178.13 +/- 79.41 222.40 +/- 95.51 0.3 
 
Data are means +/- SDs, P value, ASB: Asymptomatic bacteriuria, UTI: Urinary tract infection 
 
Discussion 
In this study, we found that the prevalence of 
ASB was higher in women with diabetes 
than in women without diabetes. In addition, 
Escherichia coli was the predominant mi-
croorganism isolated from diabetic patients. 
These findings were confirmed by other re-
ports (1, 4, 6, 8, 10, 15). Makuyana and co-
workers (11) isolated Staphylococcus aureus, 
Streptococcus and Pseudomonas spp. from 
diabetic women with ASB. In our study, 
such isolates were not prevalent.  
Although, age has also postulated as the 
most important risk factor for ASB in type 2 
diabetic patients in some reports (14, 23), in 
the current study we could not find an asso-
ciation between age and the presence of 
ASB in diabetic women. In contrast, as it is 
shown in Table 2, age of patients was an im-
portant risk factor for developing UTI in dia-
betic women with ASB. It is shown in this 
study that, the average of the age in diabetic 
women with UTI was lower than patients 
without UTI. Therefore, it can be concluded 
that, other factors such as sexual activity and 
menstrual period in young diabetic women 
may be included as predisposing factors for 
developing ASB to symptomatic UTI. This 
finding has the value for future studies and 
investigations. 
 Another risk factor for ASB in type 2 dia-
betic patients in this study was at least one 
episode of UTI during the previous year. 
Previous UTI as a risk factor for ASB indi-
cates that bacteriuria can be present with or 
without symptoms in the same patient. In 
some reports (14, 23- 25) the presence of 
UTI during past year, has also been postu-
lated as important risk factor of ASB in dia-
betics. It can be concluded that, the coloni-
zation of uropathogens in urinary tract of 
diabetics after episodes of UTI and also local 
secretion of cytokines and increased adher-
ence of bacteria to uroepithelial cells in these 
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patients, can accelerate the prolonged release 
of bacteria from urinary tract which may 
cause bacteriuria.  
Some studies (26) found that diabetic women 
with ASB had lower urinary cytokine con-
centrations and therefore decreased urinary 
leukocyte numbers compared with nondia-
betic women with ASB. But, in our study, 
80% of women with type 2 diabetes and 
ASB had pyuria compared to 25% in non 
diabetic women. The correlation between py-
uria and ASB has also been reported by 
other studies (7, 10, 11, 15). Meiland and as-
sociates (19) have reported that decreasing 
renal functional tests is a consequence of 
ASB in diabetic patients and therefore, they 
recommended screening of diabetic patients 
for ASB. Geerlings (20) showed that 34% of 
diabetic women with ASB had impaired 
renal functional tests. In our study, we did 
not find any association between patients, 
serum creatinine and presence of ASB. 
Some reports (4, 7, 8, 10, 27) have showed 
that the duration of diabetes is associated 
with ASB in diabetic patients. In the present 
study, we could not find any association 
between duration of diabetes and presence of 
ASB in diabetes type 2 women. Meilland 
(14) has also reported that this relationship 
was not present in patients with diabetes 
type 2 and only was found between ASB and 
diabetes type 1. 
Geerlings (20) showed that 23% of patients 
with diabetes type 2 and ASB developed to 
symptomatic UTI within 2 months and pos-
tulated that ASB was the most important risk 
factor for developing UTI in diabetic women. 
These findings have been confirmed by Ooi 
and coworkers (4). In this study, after a six 
months follow-up of diabetic women with 
ASB, a considerable percentage of patients, 
developed to symptomatic UTI. Therefore, 
we can conclude that ASB could be consid-
ered an essential risk factor for developing 
UTI in diabetic patients.  
No consensus exists regarding the treatment 
of ASB in diabetic patients. Many experts 
recommend treating ASB in diabetic patients 
because of the frequency and severity of up-
per UTIs (6, 23, 28). On the other hand, some 
studies believe that the benefit of treatment 
is doubtful (4, 29). This contrast is believed 
as a lack of follow-up studies of diabetic 
women with untreated ASB. In this study, as 
mentioned above, after a six months follow-
up of diabetic women with ASB, 40% de-
veloped to symptomatic UTI. Therefore, al-
though a further investigation about ap-
proach in diabetic patients with ASB is sug-
gested, based on our findings, we recom-
mend screening and treatment of ASB in 
diabetic women.  
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